Knott David M Jr »

Biogen Idec shares owned by Knott David M Jr

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Knott David M Jr from 13F filings

Historical chart of Knott David M Jr investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Knott David M Jr consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Knott David M Jr

Quarter filed Position value Share count Share price at filing
2025-09-30 $280k 2.0k 140.08

More positions owned by Knott David M Jr

Calumet Common (CLMT)
Apollo Global Management Common (APO)
Alphabet Inc-Cl C Common (GOOG)
Janus Henderson AAA CLO ETF Common (JAAA)
Darling Ingredients Common Call Option (DAR)
Xeris Biopharma Holdings Common (XERS)
Syndax Pharmaceutical Common (SNDX)
JPMorgan Chase & Co. Common (JPM)
Travere Therapeutics Common (TVTX)
Avadel Pharmaceuticals Common (AVDL)
Protagonist Therapeutics Common (PTGX)
Bridgebio Pharma Common (BBIO)
DocGo Common (DCGO)
Verona Pharma Common (VRNA)
LENZ Therapeutics Common (LENZ)

View all positions for Knott David M Jr

Top funds holding Biogen Idec

Vanguard Group
BlackRock
PRIMECAP Management Company
State Street Corporation
Wellington Management Company
Geode Capital Management
Point72 Asset Management
Norges Bank Investment Management
Susquehanna International
AQR Capital Management
Robeco Investment Management
Invesco
Barclays
Legal & General Group
Millennium Management

View all funds holding Biogen Idec